Created at	Source	Raw Value	Validated value
Jan. 12, 2022, 9 a.m.	usa	Antibody seroconversion rate to SARS CoV-2 Spike protein 29 days after the second vaccination.	Antibody seroconversion rate to SARS CoV-2 Spike protein 29 days after the second vaccination.
Dec. 31, 2020, 12:31 a.m.	usa	Incidence of Serious Adverse Events (SAEs) post first dose until the study end	Incidence of Serious Adverse Events (SAEs) post first dose until the study end